Welcome back to the March issue of Updates from the Lab! We are thrilled to share our most recent sequencing updates, breaking news, and information about our research programs.
“Jeffrey’s Insights” Genetic Sequencing Program
As of January 2023:
- Total of 3,754 patients tested (US - 889, INT – 2,874)
- Total variants identified: 22,850
Breaking News
Last month we announced our collaboration with Veritas, a letsgetchecked company, which aims to increase genomic diagnosis in the field of immunological disorders. Read the full press release here.
“We are excited to begin our journey with Veritas to enhance our gene sequencing program and continue to give hope, improve the quality of life, and in some cases, cure children with PI worldwide.” – Vicki and Fred Modell, Co-Founders, Jeffrey Modell Foundation.
Translational Research Program
Applications for Cycle 11 of our Translational Research Program are now open! Learn about how to submit your letter of intent before March 14.
Specific Defect
The goal of the Specific Defect program is to support research that studies the mechanisms and presentation of specific defects of the immune system to gain a better understanding of the defects and their impact on overall health outcomes. Awards are granted on a rolling basis throughout the year. Each award amounts up to $50,000 over a two-year project period, with a maximum of $25,000 per year. Apply here.
c.h.i.l.d.r.e.n!
The purpose of the of c.h.i.l.d.r.e.n! grant is to support research focused on children living with PI throughout the world, while addressing healthcare disparities, especially in developing countries, through education, testing, diagnosis, and treatment. Awards are granted on a rolling basis throughout the year. Each award amounts up to $25,000 per year, for up to two years, per grant, following peer-review and approval. Apply here.